Literature DB >> 33912678

Morphine Induces Upregulation of Neuronally Expressed CB2 Receptors in the Spinal Dorsal Horn of Rats.

Patrick Grenier1, Adam Sunavsky1, Mary C Olmstead1,2.   

Abstract

Background: Cannabinoid receptors play a key role in regulating numerous physiological processes, including immune function and reward signaling. Originally, endocannabinoid contributions to central nervous system processes were attributed to CB1 receptors, but technological advances have confirmed the expression of CB2 receptors in both neurons and glia throughout the brain. Mapping of these receptors is less extensive than for CB1 receptors, and it is still not clear how CB2 receptors contribute to processes that involve endocannabinoid signaling.
Objectives: The goal of our study was to assess the effects of peripheral nerve injury and chronic morphine administration, two manipulations that alter endocannabinoid system function, on CB2 receptor expression in the spinal dorsal horn of rats.
Methods: Twenty-four male Sprague Dawley rats were assigned to chronic constriction injury (CCI), sham surgery, or pain naïve groups, with half of each group receiving once daily injections of morphine (5 mg/kg) for 10 days. On day 11, spinal cords were isolated and prepared for fluorescent immunohistochemistry. Separate sections from the deep and superficial dorsal horn were stained for neuronal nuclei (NeuN), CD11b, or 4',6-diamidino-2-phenylindole (DAPI) to mark neurons, microglia, and cell nuclei, respectively. Double labeling was used to assess colocalization of CB2 receptors with NeuN or microglial markers. Quantification of mean pixel intensity for each antibody was assessed using a fluorescent microscope, and CB2 receptor expressing cells were also counted manually.
Results: Surgery increased DAPI cell counts in the deep and superficial dorsal horn, with CCI rats displaying increased CD11b labeling ipsilateral to the nerve injury. Surgery also decreased NeuN labeling in both regions, an effect that was blocked by morphine administration. CB2 receptors were expressed, predominantly, on NeuN-labeled cells with significant increases in CB2 receptor labeling across all surgery groups in both deep and superficial areas following morphine administration. Conclusions: Our findings provide supporting evidence for the expression of CB2 receptors on neurons and reveal upregulation of receptor expression in the dorsal spinal cord following surgery and chronic morphine administration, with the latter producing a larger effect. Synergistic effects of morphine-cannabinoid treatments, therefore, may involve CB2-mu opioid receptor interactions, pointing to novel therapeutic treatments for a variety of medical conditions. Copyright 2021, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  CCI; chronic pain; gliosis; opiate; opioid

Mesh:

Substances:

Year:  2021        PMID: 33912678      PMCID: PMC8064965          DOI: 10.1089/can.2020.0004

Source DB:  PubMed          Journal:  Cannabis Cannabinoid Res        ISSN: 2378-8763


  46 in total

1.  Exposure to morphine affects the expression of endocannabinoid receptors and immune functions.

Authors:  Qing-Yu Zhang; Min Zhang; Yi Cao
Journal:  J Neuroimmunol       Date:  2012-04-27       Impact factor: 3.478

Review 2.  Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.

Authors:  Nimish Sidhpura; Loren H Parsons
Journal:  Neuropharmacology       Date:  2011-06-12       Impact factor: 5.250

Review 3.  The endocannabinoid system and the brain.

Authors:  Raphael Mechoulam; Linda A Parker
Journal:  Annu Rev Psychol       Date:  2012-07-12       Impact factor: 24.137

Review 4.  Targeting the endocannabinoid system: future therapeutic strategies.

Authors:  Oier Aizpurua-Olaizola; Izaskun Elezgarai; Irantzu Rico-Barrio; Iratxe Zarandona; Nestor Etxebarria; Aresatz Usobiaga
Journal:  Drug Discov Today       Date:  2016-08-20       Impact factor: 7.851

Review 5.  Neuroinflammation and Central Sensitization in Chronic and Widespread Pain.

Authors:  Ru-Rong Ji; Andrea Nackley; Yul Huh; Niccolò Terrando; William Maixner
Journal:  Anesthesiology       Date:  2018-08       Impact factor: 7.892

Review 6.  Progress in brain cannabinoid CB2 receptor research: From genes to behavior.

Authors:  Chloe J Jordan; Zheng-Xiong Xi
Journal:  Neurosci Biobehav Rev       Date:  2019-01-03       Impact factor: 8.989

7.  Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Jian-Ping Gong; Sejal Patel; Paul A Meozzi; Lester Myers; Alex Perchuk; Zoila Mora; Patricia A Tagliaferro; Eileen Gardner; Alicia Brusco; B Emmanuel Akinshola; Qing-Rong Liu; Sanika S Chirwa; Bruce Hope; Javier Lujilde; Toshiya Inada; Shinya Iwasaki; David Macharia; Lindsey Teasenfitz; Tadao Arinami; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.

Authors:  A Vanessa Stempel; Alexander Stumpf; Hai-Ying Zhang; Tuğba Özdoğan; Ulrike Pannasch; Anne-Kathrin Theis; David-Marian Otte; Alexandra Wojtalla; Ildikó Rácz; Alexey Ponomarenko; Zheng-Xiong Xi; Andreas Zimmer; Dietmar Schmitz
Journal:  Neuron       Date:  2016-04-28       Impact factor: 17.173

9.  Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared.

Authors:  A L Ford; A L Goodsall; W F Hickey; J D Sedgwick
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

10.  Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference.

Authors:  Qing-Rong Liu; Ana Canseco-Alba; Hai-Ying Zhang; Patricia Tagliaferro; Monika Chung; Eugene Dennis; Branden Sanabria; Norman Schanz; Joao Carlos Escosteguy-Neto; Hiroki Ishiguro; Zhicheng Lin; Susan Sgro; Claire M Leonard; Jair Guilherme Santos-Junior; Eliot L Gardner; Josephine M Egan; Jeung Woon Lee; Zheng-Xiong Xi; Emmanuel S Onaivi
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

View more
  1 in total

Review 1.  Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation.

Authors:  Nynke J van den Hoogen; Erika K Harding; Chloé E D Davidson; Tuan Trang
Journal:  Front Neural Circuits       Date:  2022-01-07       Impact factor: 3.492

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.